M Llovera
Overview
Explore the profile of M Llovera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
578
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cornago M, Garcia-Alberich C, Blasco-Angulo N, Vall-Llaura N, Nager M, Herreros J, et al.
Cell Death Dis
. 2014 Oct;
5:e1435.
PMID: 25275596
Glioblastoma multiforme is resistant to conventional anti-tumoral treatments due to its infiltrative nature and capability of relapse; therefore, research efforts focus on characterizing gliomagenesis and identifying molecular targets useful on...
2.
Zhang J, Bahi N, Llovera M, Comella J, Sanchis D
Cell Death Differ
. 2009 Jul;
16(11):1460-8.
PMID: 19590510
Cardiac morphologic abnormalities in mice deficient for key regulators of the caspase-dependent signaling underscored its role in heart development. However, the mechanisms regulating apoptotic gene expression in the developing heart...
3.
Bernichtein S, Kinet S, Jeay S, Llovera M, Madern D, Martial J, et al.
Endocrinology
. 2001 Aug;
142(9):3950-63.
PMID: 11517174
For many years, our group has been involved in the development of human PRL antagonists. In two recent publications, S179D-human PRL, a human PRL analog designed to mimic a putative...
4.
Ammarguellat F, Llovera M, Kelly P, Goffin V
Biochem Biophys Res Commun
. 2001 Jun;
284(4):1031-8.
PMID: 11409898
Previous reports have shown a direct effect of erythropoietin (Epo) on vascular smooth muscle cells (VSMCs). Our aim was to assess expression of the Epo receptor (EpoR) on VSMCs and...
5.
Llovera M, Pearson J, Moreno C
Br J Pharmacol
. 2001 Feb;
132(2):419-26.
PMID: 11159690
1. Inducible NO synthase (iNOS) expression and activity were measured in the mouse macrophage cell line J774 after exposure to bacterial lipopolysaccharide (LPS) with or without interferon-gamma (IFN-gamma). 2. Inhibition...
6.
Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly P, et al.
Oncogene
. 2000 Oct;
19(41):4695-705.
PMID: 11032019
The involvement of human prolactin (hPRL) in breast cancer has been recently reconsidered based on its autocrine/paracrine proliferative effect described in human mammary tumor epithelial cells. Therefore, there is growing...
7.
Busquets S, Alvarez B, Llovera M, Agell N, Lopez-Soriano F, Argiles J
J Cell Physiol
. 2000 Jul;
184(3):380-4.
PMID: 10911370
Incubation of isolated rat soleus and EDL muscles in the presence of 10 mM leucine resulted in a decreased proteolytic rate as measured by the release of tyrosine into the...
8.
Velazquez C, Llovera M, Plana J, Canela R
J Chromatogr A
. 2000 Mar;
870(1-2):469-72.
PMID: 10722104
The effect of several solvent systems on the chromatographic response of fumonisin B1 and B2 derived with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AccQ.Fluor) is described. Naturally contaminated corn samples were extracted and purified...
9.
Llovera M, Touraine P, Kelly P, Goffin V
Exp Gerontol
. 2000 Mar;
35(1):41-51.
PMID: 10705038
The mammary gland is the major target tissue of prolactin (PRL) in mammals. Although this pituitary hormone has been long suspected to be involved in the progression of human breast...
10.
Velazquez C, Llovera M, Pena E, Sala N, Canela R
Food Addit Contam
. 1999 Sep;
16(3):125-8.
PMID: 10492705
Fumonisins are produced by several fungal species that are common contaminants of maize. The most abundant naturally occurring fumonisin, fumonisin B1 (FB1), has been shown to induce several animal disease...